• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Neutralising immunity to omicron sublineages BQ.1.1, XBB, and XBB.1.5 in healthy adults is boosted by bivalent BA.1-containing mRNA vaccination and pr

Mary Wilson

Well-known member
Published: June 05, 2023

DOI: https://doi.org/10.1016/S1473-3099(23)00289-X

Edward J Carr , Mary Y Wu , Joshua Gahir, Ruth Harvey, Hermaleigh Townsley, Chris Bailey, et al.​​

The global COVID-19 landscape is increasingly complex; emerging new variants rapidly cause waves of infection in people with variably induced immunity. Most individuals now have so-called hybrid immunity from both infection and vaccination. However, sequential infecting variants, induction of immunity, and subsequent waning are interlinked, and immune protection against new variants is unclear.
In the UK, the Living with COVID-19 strategy is based on the assumption that high population hybrid immunity will continue to blunt the severity and duration of COVID-19 waves. What happened in Singapore in late 2022 suggests that this might be a fragile assumption. Omicron subvariant XBB caused more than 45 000 cases, including more than 36 000 primary infections, despite vaccination rates of more than 90%; admissions and deaths rose marginally.[SUP]1[/SUP][SUP], [/SUP][SUP]2[/SUP] One study on reinfection cases in Singapore in The Lancet Infectious Diseases reported that hybrid immunity from vaccination and infection with pre-omicron variants did not confer protection against XBB reinfection.
[SUP]1[/SUP] Although it is tempting to assign causation to immune memory,[SUP]3[/SUP] this observation is underpinned by marked population heterogeneity including: differing early infection exposure, waning, or antigenic distance between inducing and re-challenge variants.​ ...

https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(23)00289-X/fulltext
 
Back
Top Bottom